ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 387

$676K Total Retail Price of All Prescriptions

Rank: 81 out of 387

750 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 750 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 750 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 10,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 405 384 1 3
HYDROCODONE-ACETAMINOPHEN 390 259 S3 2 1
LEVOTHYROXINE SODIUM 372 338 3 2
FUROSEMIDE 328 294 4 7
OMEPRAZOLE 311 283 5 4
METFORMIN HCL 298 253 6 8
METOPROLOL TARTRATE 279 248 7 11
POTASSIUM CHLORIDE 253 225 8 9
PRAVASTATIN SODIUM 236 229 9 15
AMLODIPINE BESYLATE 232 214 10 6
WARFARIN SODIUM 221 214 11 17
SIMVASTATIN 215 203 12 5
ATENOLOL 183 160 13 20
HYDROCHLOROTHIAZIDE 180 175 14 12
METOPROLOL SUCCINATE 154 150 15 18
ATORVASTATIN CALCIUM 137 94 16 13
TRAMADOL HCL 135 119 17 14
GABAPENTIN 135 115 17 10
FLUOXETINE HCL 133 125 19 46
ZOLPIDEM TARTRATE 127 118 20 16
CARVEDILOL 113 103 21 21
TAMSULOSIN HCL 110 110 22 32
SYNTHROID 109 74 23 68
RANITIDINE HCL 103 96 24 45
TRIAMTERENE-HCTZ 99 93 25 55
DOXYCYCLINE HYCLATE 99 75 25 114
PANTOPRAZOLE SODIUM 96 67 27 48
CYCLOBENZAPRINE HCL 96 72 R 27 42
CRESTOR 95 93 29 34
CITALOPRAM HBR 95 93 29 19
CLOPIDOGREL 94 87 31 25
AZITHROMYCIN 93 76 32 49
ADVAIR DISKUS 92 71 33 41
LOSARTAN POTASSIUM 89 75 34 24
DIOVAN HCT 89 79 34 74
DIGOXIN 84 84 36 40
FLUTICASONE PROPIONATE 83 75 37 29
SPIRIVA 80 68 38 61
CLONIDINE HCL 78 64 39 38
METHYLPREDNISOLONE 77 64 40 101
PREDNISONE 77 67 40 43
LEVOFLOXACIN 76 66 42 84
NADOLOL 73 73 43 261
PLAVIX 73 69 43 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 62 43 30
LOVASTATIN 72 72 46 36
NAPROXEN 71 62 47 89
SERTRALINE HCL 69 50 48 23
AMIODARONE HCL 68 58 49 156
ALLOPURINOL 64 57 50 28
ALENDRONATE SODIUM 61 61 51 31
TRAZODONE HCL 61 49 51 37
CELEBREX 61 61 51 72
GLYBURIDE 57 57 R 54 58
ACTOS 56 56 55 99
HYDROMORPHONE HCL 56 21 S2 55 273
SPIRONOLACTONE 55 49 57 67
ESCITALOPRAM OXALATE 54 51 58 73
PREMARIN 53 32 R 59 77
LOSARTAN-HYDROCHLOROTHIAZIDE 53 46 59 65
GEMFIBROZIL 52 39 61 93
VERAPAMIL ER 52 52 61 87
KLOR-CON M20 52 47 61 76
AMLODIPINE BESYLATE-BENAZEPRIL 50 45 64 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.